FDA Puts Partial Hold on Investigational Alopecia Drug FDA Puts Partial Hold on Investigational Alopecia Drug

A pulmonary embolism occurred in a patient on the 12-mg dose, so testing was put on hold for that dose. There is no hold on the 8-mg dose.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news